ArticleClinical ophthalmology (Auckland, N.Z.)2025
Comparison of Subconjunctival Triamcinolone with Topical Prednisolone for Routine Anti-Inflammatory Prophylaxis in Manual Small Incision Cataract Surgery: A Single-Center, Randomized Controlled Trial Pilot Protocol.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05248139 (Safety and Effectiveness of Single-dose Subconjunctival Triamcinolone Compared to Topical Prednisolone Eye Drops in Manual Small Incision Cataract Surgery), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Safety and Effectiveness of Single-dose Subconjunctival Triamcinolone Compared to Topical Prednisolone Eye Drops in Manual Small Incision Cataract Surgery
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cataract surgery is the most commonly performed operation worldwide. Prophylaxis against postoperative endophthalmitis and inflammation currently includes perioperative, patient-administered instillation of topical antibiotic and anti-inflammatory drops in the US, Europe and Latin America. As patients can face challenges with adherence to topical drops for self-instillation, injected drugs may offer a solution. Intracameral antibiotic injection is superior to drops for endophthalmitis prevention in manual small incision surgery (MSICS) and phacoemulsification eyes. Subconjunctival injection of triamcinolone acetonide (TA) is an effective method to prevent postoperative inflammation in phacoemulsification eyes. MSICS may be associated with more tissue trauma because of the larger incision size and iris manipulation. As there are no studies to date comparing injection prophylaxis with topical drops in MSICS eyes for postoperative inflammation prevention, this pilot study aims to elucidate the safety of the injection technique in this method of cataract surgery. Methods/Design: This is a single-center, partially-masked, pilot randomized controlled trial of two groups undergoing uncomplicated MSICS. Group 1 consists of a single eye of 50 patients treated with the standard postoperative topical drops, prednisolone acetate (PA) 1%, starting four times a day in the first week tapering by one drop per week over 4 weeks. Group 2 consists of a single eye of 50 patients injected with 0.4mL of TA subconjunctivally at the conclusion of MSICS. Intracameral moxifloxacin 0.15% is injected at the end of surgery in both groups. Postop measurements are taken on day 2, and at weeks 6 and 12. The primary outcome, a safety measure, is mean intraocular pressure (IOP). Secondary outcomes, effectiveness measures, include corrected distance visual acuity (CDVA), anterior chamber inflammation, corneal and macular edema (ME). Discussion: The objective of this study is to evaluate the safety and efficacy of a single subconjunctival TA injection compared to standard postoperative topical therapy using PA 1% in eyes undergoing MSICS. Trial Details: Clinicaltrials.gov: NCT05248139; Protocol issue date: August 9, 2024; Amendment number: 02.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.